Sam plans to his opponent Elon Musk’s Neuralink star-news.press/wp

Sam Al -Tamman plans in his next step against Elon Musk, with plans for the Neuralink competitor.

Openai is planning to invest in the start of brain transplantation, Financial times I mentioned Tuesday.

The new company, called Merge Labs, aims to integrate people and machines together through artificial intelligence and collect funds with a value of $ 850 million, according to FT.

According to what the startup aims to raise $ 250 million in the total investment, it is expected that the Openai’s Ventures team will provide a lot of new capital.

The published sources told that Altman will praise the company alongside Alex Blania, founder and CEO of World, another emerging backed by Openai that uses eye products to provide anonymous digital identity. However, Altman will not personally invest in incorporation laboratories.

The company will be a direct competitor to Elon Musk’s Neuralink, which also aims to connect computers and human brains by planting brain chips.

Last month, Musk told investors that he planned to plant 20,000 people annually with Neuralink chips by 2031. If it succeeds, this plant will generate an estimated billion dollars of the company’s annual revenues, Bloomberg I mentioned.

The billionaire entrepreneurs, who founded Openai together, were face to the race to control the artificial intelligence market. He left Musk Openai in 2018 and continued to launch his AI’s start, which is called Xai in 2023. Earlier this year, he was A lawsuit against Openai To prevent the transfer of the company without profitability to profit.

On Monday, Musk claimed that Apple violates anti -monopoly laws by maintaining Openai as the best AI app in the application store. “XAI will take immediate legal measures,” he wrote in A. After x. Al -Tamman responded to his position On x In claiming that Musk is manipulating X by “taking advantage of himself and his companies and harms his competitors and the people he does not like.”